Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,651
Total Claims
$1.3M
Drug Cost
485
Beneficiaries
$2,601
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+84%
Cost per patient vs peers
$2,601 vs $1,411 avg
-12%
Brand preference vs peers
9.4% vs 10.6% avg
Brand vs Generic
Brand: 950 claims · $944K
Generic: 9,175 claims · $301K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 158 | $261K |
| Sitagliptin Phosphate | 75 | $121K |
| Icosapent Ethyl | 89 | $80K |
| Sitagliptin Phos/Metformin Hcl | 52 | $64K |
| Rosuvastatin Calcium | 684 | $57K |
| Semaglutide | 36 | $56K |
| Diclofenac Sodium | 759 | $54K |
| Dapagliflozin Propanediol | 20 | $37K |
| Finerenone | 20 | $37K |
| Budesonide/Formoterol Fumarate | 40 | $36K |
| Empagliflozin/Metformin Hcl | 14 | $22K |
| Albuterol Sulfate | 258 | $18K |
| Ezetimibe | 253 | $18K |
| Fluticasone Propion/Salmeterol | 18 | $16K |
| Atorvastatin Calcium | 584 | $16K |
Prescribing Profile
Patient Profile
72
Avg Age
50%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data